AHC
EW icon

Anderson Hoagland & Co’s Edwards Lifesciences EW Stock Holding History

Anderson Hoagland & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-45,420
Closed -$1.82M – 103
2016
Q3 		$1.82M Buy
+45,420
New +$1.71M 1.05% 39

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Anderson Hoagland & Co's EW Position: Q4 2016 in Review

Anderson Hoagland & Co sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 45,420 shares — an estimated $1.82M sold.

Anderson Hoagland & Co first reported a position in EW in Q3 2016 and held it in 1 quarter. The position peaked at $1.82M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • Anderson Hoagland & Co reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
  • Anderson Hoagland & Co sold 45,420 Edwards Lifesciences shares in Q4 2016, an estimated $1.82M.
  • Anderson Hoagland & Co first reported a position in Edwards Lifesciences in Q3 2016 and held it in 1 quarter.
  • Anderson Hoagland & Co's Edwards Lifesciences position peaked at $1.82M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Anderson Hoagland & Co's 13F filing for Q4 2016, filed 24 Jan 2017.